AnvilCore Research
KLOW research material is available in the strength shown below. Select a tab to review the available format.
Technical research description
KLOW is a research blend containing GHK-Cu, BPC-157, TB-500, and the alpha-MSH-derived tripeptide KPV. The components are individually studied in extracellular-matrix, cell-migration, vascular, and inflammatory-signaling models; the fixed four-component blend has not been validated as a single formulation in controlled studies.
KLOW is a research blend containing GHK-Cu, BPC-157, TB-500, and the alpha-MSH-derived tripeptide KPV. The components are individually studied in extracellular-matrix, cell-migration, vascular, and inflammatory-signaling models; the fixed four-component blend has not been validated as a single formulation in controlled studies.
Component sequences
GHK-Cu: Gly — His — Lys · Cu²⁺
BPC-157: Gly — Glu — Pro — Pro — Pro — Gly — Lys — Pro — Ala — Asp — Asp — Ala — Gly — Leu — Val
TB-500 fragment: Ac — Leu — Lys — Lys — Thr — Glu — Thr — Gln
KPV: Lys — Pro — Val
BPC-157: Gly — Glu — Pro — Pro — Pro — Gly — Lys — Pro — Ala — Asp — Asp — Ala — Gly — Leu — Val
TB-500 fragment: Ac — Leu — Lys — Lys — Thr — Glu — Thr — Gln
KPV: Lys — Pro — Val
Four-component research blend.
KLOW — 80 mg
- Strength
- 80 mg
- Format
- Powder
- Retail price (USD)
- $68.00
Adds KLOW — 80 mg to your cart. Research and laboratory use only.
Research use only. Not for human consumption or clinical, diagnostic, or therapeutic use.
Certificate of Analysis
Tested label claim: GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
Reported sample lot: T-KLO-0030
Report issued: November 9, 2026
Report: AX-2026-1561-RPUP – Axiom Analytics
This report applies only to the tested sample identified by the listed lot and label claim. It does not cover other strengths or establish safety, efficacy, or suitability for human or animal use.